Mechanistic Insights of Aberrant Splicing with Splicing Factor Mutations Found in Myelodysplastic Syndromes

• Published in: International journal of molecular sciences 2021-08, Vol.22 (15), p.7789
• Main Authors: Kataoka, Naoyuki, Matsumoto, Eri, Masaki, So
• Format: Article
• Language: English
• Subjects: Acute myeloid leukemia; Binding sites; DNA repair; Eukaryotes; exon recognition; Exons; Exports; Gene expression; Genes; Genomes; Leukemia; MDS; Mutation; Myelodysplastic syndrome; Myelodysplastic syndromes; Myeloid leukemia; Neoplasms; Proteins; Regulatory sequences; Review; Signs and symptoms; Splicing; splicing factor mutations; Splicing factors
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms22157789

Pre-mRNA splicing is an essential process for gene expression in higher eukaryotes, which requires a high order of accuracy. Mutations in splicing factors or regulatory elements in pre-mRNAs often result in many human diseases. Myelodysplastic syndrome (MDS) is a heterogeneous group of chronic myeloid neoplasms characterized by many symptoms and a high risk of progression to acute myeloid leukemia. Recent findings indicate that mutations in splicing factors represent a novel class of driver mutations in human cancers and affect about 50% of Myelodysplastic syndrome (MDS) patients. Somatic mutations in MDS patients are frequently found in genes SF3B1, SRSF2, U2AF1, and ZRSR2. Interestingly, they are involved in the recognition of 3′ splice sites and exons. It has been reported that mutations in these splicing regulators result in aberrant splicing of many genes. In this review article, we first describe molecular mechanism of pre-mRNA splicing as an introduction and mainly focus on those four splicing factors to describe their mutations and their associated aberrant splicing patterns.